819963008: Brolucizumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Vascular endothelial growth factor receptor antagonist\Brolucizumab

\Drug or medicament (substance)\Monoclonal antibody\Brolucizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Brolucizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Brolucizumab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Brolucizumab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Brolucizumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Brolucizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3858363017 Brolucizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3858364011 Brolucizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3858363017 Brolucizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3858364011 Brolucizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

369161000195110 brolucizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1132981000241114 brolucizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1132981000241114 brolucizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

369161000195110 brolucizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brolucizumab	Is a	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Brolucizumab	Has disposition	Vascular endothelial growth factor receptor antagonist	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Brolucizumab	Is a	Vascular endothelial growth factor receptor antagonist	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Brolucizumab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brolucizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Brolucizumab-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brolucizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing brolucizumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brolucizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Brolucizumab only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Brolucizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely brolucizumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Brolucizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely brolucizumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Brolucizumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets